Nektar Therapeutics - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
NKTR Nasdaq 8731 http://www.nektar.com 13.50 Stock Down -0.10

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Nektar Therapeutics

NEKTAR THERAPEUTICS Financials - Mar 6th, 2014 11:04 am
Nektar Therapeutics (NKTR) Jumps: Stock Up 10.5% - Mar 3rd, 2014 11:16 pm
NEKTAR THERAPEUTICS Files SEC form 10-K, Annual Report - Feb 27th, 2014 2:27 pm
Nektar Therapeutics downgraded by MKM Partners - Feb 27th, 2014 8:36 am
Wider-than-Expected Loss at Nektar, Guidance Disappoints - Feb 27th, 2014 8:10 am
Today's Biggest Stories in Biotech: Galectin Therapeutics Inc, Merrimack Pharmaceuticals and Nektar Therapeutics - Feb 27th, 2014 7:27 am
Nektar Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript - Feb 26th, 2014 7:50 pm
Nektar Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results - Feb 26th, 2014 3:43 pm
NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib - Feb 26th, 2014 2:21 pm
Nektar Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results - Feb 26th, 2014 2:15 pm
Q4 2013 NEKTAR THERAPEUTICS Earnings Release - After Market Close - Feb 26th, 2014 5:07 am
Use Options For A Chance To Buy NKTR At A 42% Discount - Feb 24th, 2014 9:53 am
Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2013 on Wednesday, February 26, 2014, After Close of U.S.-Based Financial Markets - Feb 19th, 2014 3:16 pm
Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2013 on Wednesday, February 26, 2014, After Close of U.S.-Based Financial Markets - Feb 19th, 2014 2:15 pm
NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure - Feb 11th, 2014 2:27 pm
Nektar bull buys time for a rally - Feb 7th, 2014 2:45 am
Can Nektar Therapeutics Beat Pfizer Inc.? - Feb 4th, 2014 9:26 am
NEKTAR THERAPEUTICS Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Jan 28th, 2014 4:03 am
Nektar Therapeutics (NKTR) Looks Good: Stock Up 6.8% in Session - Jan 23rd, 2014 11:34 pm
Nektar Therapeutics Prices Public Offering of Common Stock - Jan 22nd, 2014 8:09 pm